Nov 12, 2019 -
It’s been a rough 2019 for some biotechs. Amneal Pharmaceuticals Inc (NYSE: AMRX) is down 81% year-to-date, while Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is down 41%.
Nov 11, 2019 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Nov 08, 2019 - Aimed at rolling over three series of outstanding debt due in 2021, Teva Pharmaceutical Industries (TEVA +4.5%) launches a $1.5B private offering Euro-denominated Senior Notes.Pricing and terms have y
Nov 08, 2019 - Teva Pharmaceutical (TEVA) misses earnings estimate but beats the same for sales. The company increases the lower end of its 2019 sales and earnings guidance. Shares rise.
Nov 08, 2019 - The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2019 Q3 earnings call.
Nov 08, 2019 - P/B ratio is emerging as a convenient tool for identifying low-priced stocks that have high growth prospects.
Nov 07, 2019 - Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q3 2019 Results Conference Call November 07, 2019 08:00 AM ET Company Participants Kevin Mannix - Senior Vice President of Investor Relations Kare Sc
Nov 07, 2019 - Investors grew optimistic that the company's legal and financial risks from the ongoing opioid epidemic may be coming to an end.
Nov 07, 2019 - TEVA earnings call for the period ending September 30, 2019.
Nov 07, 2019 - Teva Pharmaceutical (TEVA) misses earnings estimate but beats the same for sales. Shares rise in pre-market trading.